ENXTPA:SAN
ENXTPA:SANPharmaceuticals

Is Now the Moment to Revisit Sanofi Shares After a Recent 11% Jump?

If you’re on the fence about Sanofi, you’re definitely not alone. There has been a lot of back-and-forth among investors lately about whether this is a great time to hold or even add to a position, or if it is better to stay on the sidelines until the dust settles. Sanofi’s stock has shown real signs of life over the last month, climbing 11.4% as optimism returns to the broader pharmaceutical sector and confidence grows around its product pipeline. However, the year-to-date return is still...
ENXTPA:RI
ENXTPA:RIBeverage

Pernod Ricard (ENXTPA:RI): Assessing Valuation Following AGM-Backed Dividend and Board Renewals

Pernod Ricard (ENXTPA:RI) caught investors’ attention after its Annual General Meeting, where shareholders approved all resolutions, including confirmation of the annual dividend and several key board appointments. This combination sets a clear tone for the months ahead. See our latest analysis for Pernod Ricard. Even with recent board appointments and steady dividend policy providing a tone of stability, Pernod Ricard’s share price momentum has struggled to regain its previous highs. After a...
ENXTPA:CAP
ENXTPA:CAPIT

Capgemini (ENXTPA:CAP) Valuation in Focus as Investors Reassess Prospects

Capgemini (ENXTPA:CAP) shares have moved modestly, with little in the way of major headlines to spark a dramatic shift. Still, recent investor interest hints at ongoing curiosity about valuations as the company continues to navigate current market conditions. See our latest analysis for Capgemini. After a tough stretch earlier this year, Capgemini’s 1-day and 7-day share price returns of 0.8% and 3.9% hint at a bit of renewed momentum. Still, with total shareholder return down 25.8% over the...
ENXTPA:ENGI
ENXTPA:ENGIIntegrated Utilities

Engie Shares Surge 35% as Renewables Policy Boosts Growth Prospects in 2025

If you are weighing what to do with Engie shares right now, you are far from alone. The stock has delivered impressive returns lately, climbing 7.4% in the last month and notching a remarkable 35.5% gain over the past year. Even more striking is Engie’s long-term trajectory, with the stock up nearly 172% over five years. That kind of steady value creation naturally raises the question: is there still more room for growth, or is the market finally catching up with Engie’s true worth? Some of...
ENXTPA:ANTIN
ENXTPA:ANTINCapital Markets

European Stocks Trading Below Estimated Value In October 2025

As the European stock markets continue to show resilience with the pan-European STOXX Europe 600 Index rising by 1.68% and major indices such as Germany's DAX and the UK's FTSE 100 also posting gains, investors are keenly assessing opportunities that may be trading below their estimated value. In this environment of improved business activity and consumer confidence, identifying stocks that are undervalued can provide potential avenues for growth, especially when considering companies with...
ENXTPA:SAF
ENXTPA:SAFAerospace & Defense

Will Stable LEAP Engine Deliveries Shape Safran’s (ENXTPA:SAF) Competitive Edge in Aerospace?

In recent commentary, Safran's CEO reported that fourth quarter LEAP engine deliveries are expected to closely match third quarter levels, while CFM is continuing talks for a potential Boeing 737 engine deal with a Turkish airline. This update highlights both the stability of Safran’s core engine operations and the ongoing pursuit of new business opportunities within the commercial aerospace sector. We'll explore how the steady outlook for LEAP engine deliveries shapes Safran's current...